CTLA4 and neoplasm: Phung et al. [59] designed exosomes from ovalbumin (OVA) (antigen)-pulsed, activated DCs, and modified them with anti-CTLA-4 antibody, exosome (EXO)-OVA-mAb to synergize cancer vaccination with ICB against tumor.